Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus (HCV)”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01483742
What this trial is testing

Ritonavir-Boosted Danoprevir and RO5024048 in Different Combinations in Null Responder or Treatment-Naïve Patients With Chronic Hepatitis C and Compensated Cirrhosis

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 43
Testing effectiveness (Phase 2)Study completedNCT00513461
What this trial is testing

Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection

Who this might be right for
Adult Primary Liver CancerHepatitis C Infection
Chao Family Comprehensive Cancer Center 110
Not applicableUnknownNCT02511496
What this trial is testing

Status of Chronic Liver Disease in Hepatitis C Virus (HCV) Patients Coinfected With Human Immunodeficiency Virus (HIV) in Andalusia

Who this might be right for
Chronic Hepatitis CHuman Immunodeficiency Virus (HIV)
Maimónides Biomedical Research Institute of Córdoba 2,800
Testing effectiveness (Phase 2)Ended earlyNCT00874796
What this trial is testing

Efficacy and Safety Study of GS-9450 Treatment for 6 Months in Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
HCV Infection
Gilead Sciences 307
Testing effectiveness (Phase 2)Study completedNCT00983060
What this trial is testing

Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected Patients

Who this might be right for
Chronic Hepatitis C Genotype-1 Relapse
Novartis Pharmaceuticals 59
Testing effectiveness (Phase 2)Study completedNCT02745535
What this trial is testing

Safety, Tolerability and Efficacy of Sofosbuvir, Velpatasvir, and Voxilaprevir in Subjects With Previous DAA Experience

Who this might be right for
Chronic Hepatitis C
University of Maryland, Baltimore 77
Testing effectiveness (Phase 2)Study completedNCT00395421
What this trial is testing

Study to Evaluate Drug-drug Interaction Between Valopicitabine and Ribavirin

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 114
Large-scale testing (Phase 3)Study completedNCT00800735
What this trial is testing

PEGASYS (Pegylated-interferon Alfa-2a) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 30
Testing effectiveness (Phase 2)Study completedNCT00292084
What this trial is testing

An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
BioWest Therapeutics Inc 60
Large-scale testing (Phase 3)Study completedNCT02707952
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C VirusHepatitis C Virus
AbbVie 295
Large-scale testing (Phase 3)Study completedNCT00596843
What this trial is testing

Chronic Hepatitis Intervention Project for Drug Users

Who this might be right for
HIVHepatitis C
National Institute on Drug Abuse (NIDA) 851
Testing effectiveness (Phase 2)Study completedNCT01332955
What this trial is testing

Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen

Who this might be right for
Hepatitis C, ChronicHIV Infection
ANRS, Emerging Infectious Diseases 70
Testing effectiveness (Phase 2)Study completedNCT00088140
What this trial is testing

A Caspase Inhibitor in Chronic Hepatitis C (HCV) Patients

Who this might be right for
Hepatitis C, Chronic
Conatus Pharmaceuticals Inc. 204
Testing effectiveness (Phase 2)Study completedNCT02253550
What this trial is testing

Simeprevir in Combination With Sofosbuvir in Treatment-Naïve or -Experienced Adults With Chronic Genotype 4 Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C
Peter J. Ruane, M.D. 30
Not applicableStudy completedNCT00333710
What this trial is testing

Evaluating a Telehealth Treatment for Veterans With Hepatitis C and PTSD

Who this might be right for
Chronic DiseaseHepatitis CStress Disorders, Post-Traumatic
US Department of Veterans Affairs 53
Post-approval studies (Phase 4)Study completedNCT01439776
What this trial is testing

Add Vitamin D With Standard of Care for Chronic Hepatitis C Patients

Who this might be right for
Chronic Hepatitis C
Hanyang University 180
Early research (Phase 1)Study completedNCT01740791
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Participants With Chronic HCV Infection

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 103
Testing effectiveness (Phase 2)Study completedNCT00115908
What this trial is testing

Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
Human Genome Sciences Inc. 458
Not applicableUnknownNCT04208035
What this trial is testing

Hepatitis C Elimination in the Netherlands

Who this might be right for
Chronic Hepatitis c
Radboud University Medical Center 250
Large-scale testing (Phase 3)Study completedNCT02092350
What this trial is testing

Safety and Efficacy of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Participants With Chronic Hepatitis C and Chronic Kidney Disease (MK-5172-052)

Who this might be right for
Hepatitis C Virus
Merck Sharp & Dohme LLC 237
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation